Imugene (IMU)

Shares / Stock Code


Stock Exchange / Sharemarket


Imugene (IMU) is an animal health biopharmaceutical company developing and commercialising biological products for the intensively farmed pig and poultry industries. Imugene's products have advantages over existing 'health improving' products, including (1) substantially improving the health of animals;(2) improving productivity and profitability for poultry and pig producers; and (3) reducing consumer exposure to antibiotic, hormone and chemical residues by using safe biodegradable, biological treatments, thereby reducing development of antibiotic resistant ‘superbugs’.

The company is headquartered in Sydney, with offices in Melbourne and Perth. It was listed on the ASX in November 1993. The Company’s subsidiaries include Brightsun Investments Pty Ltd, VectoGen Pty Ltd, BioMimic Technologies Pty Ltd and Paragen Pty Ltd.

Its products aim to prevent diseases in animals, reduce or eliminate the use of antibiotics, harmful chemicals and drugs and reduce the level of antibiotic and chemical residue entering the human food chain. There are two Receptor Mimic Technology products offered, which is a patented method for disease control. Major customers include animal markets locally and worldwide from farmers to vets.

Imugene (IMU) Products and Services

  • Development and commercialisation of animal health products for production and companion

Imugene (IMU) Locations and Subsidiaries

Imugene Head Office
Level 20, Allendale Square, 77 St Georges Tce,
PERTH, WA 6000
Phone: 08 9440 2600
Fax: 08 9440 2699

Imugene (IMU) Share Price

Submitted by ASX Listed Company on 23 April, 2010 - 01:12